Botulinum toxin type A for treating chronic low back pain: A double blinded randomized control study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

376

Figures (1-1)

Tables (1-4)

Sum=521

Publishing Process of This Article

Item

Count

Browse

Download

Sum=14

Sep 20, 2024 (publication date) through Jul 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Clinical Trial

World J Methodol. Sep 20, 2024; 14(3): 93854
Published online Sep 20, 2024. doi: 10.5662/wjm.v14.i3.93854

Table 3 Outcome scoring in both groups

VAS: Visual analog scale; ODI: Oswestry disability index.

Citation: Jain M, Khan S, Varghese P, Tripathy SK, Mangaraj M. Botulinum toxin type A for treating chronic low back pain: A double blinded randomized control study. World J Methodol 2024; 14(3): 93854
URL: https://www.wjgnet.com/2222-0682/full/v14/i3/93854.htm
DOI: https://dx.doi.org/10.5662/wjm.v14.i3.93854